Due to dysfunctions of the serotonergic system associated with severe neuropsychiatric disorders like depression or anxiety, SERT represents an important target for both clinically relevant drugs like antidepressants and anxiolytic medicines, but also recreational drugs (Kristensen et al. 2011). This evidence concerns the gene SLC6A4 and major depressive disorder.